Document is current
Any future updates will be listed below
-
Authors
Landi, L. https://orcid.org/0000-0002-8548-4395
Leali, P. Tranquilli
Barbato, L.
Carrassi, A. M.
Discepoli, N.
Muti, P. C. M.
Oteri, G.
Rigoni, M.
Romanini, E.
Ruggiero, C.
Tarantino, U.
Varoni, E.
Sforza, N. M.
Brandi, M. L.
- License Information
-
More Information
Article History
Received: 8 March 2023
Accepted: 2 June 2023
First Online: 15 July 2023
Declarations
:
: Not applicable.
: All the authors gave their consent for publication.
: L. Landi: Nothing to disclose. P. Tranquilli Leali: Nothing to disclose. L. Barbato: Nothing to disclose. A.M. Carrassi: Nothing to disclose. N. Discepoli: Nothing to disclose. P.C.M. Muti: Nothing to disclose. G. Oteri: Nothing to disclose. M. Rigoni: Nothing to disclose. E. Romanini: Nothing to disclose. C. Ruggiero: Nothing to disclose. U. Tarantino: Nothing to disclose. E. Varoni: Nothing to disclose. N.M. Sforza: Nothing to disclose. M.L. Brandi: Honoraria: Amgen, Bruno Farmaceutici, Calcilytix, Kyowa Kirin, UCB; grants and/or speaker: Abiogen, Alexion, Amgen, Amolyt, Amorphical, Bruno Farmaceutici, CoGeDi, Echolight, Eli Lilly, Enterabio, Gedeon Richter, Italfarmaco, Kyowa Kirin, Menarini, Monte Rosa, SPA, Takeda, Theramex, UCB; consultant: Aboca, Alexion, Amolyt, Bruno Farmaceutici, Calcilytix, Echolight, Kyowa Kirin, Personal Genomics, UCB.
